CRISPR THERAPEUTICS AG (CRSP:NASDAQ)
$47.55 0.82 (1.7548%)
Analysed CRISPR THERAPEUTICS AG (CRSP:NASDAQ) News Sources
Has CRISPR Therapeutics (CRSP) Fallen Far Enough To Look Undervalued?
18-07-2026
yahoo.com
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
20-07-2026
yahoo.com
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating
22-07-2026
fool.com
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
24-07-2026
yahoo.com
Cathie Wood's Ark Bought $21.3 Million of SpaceX Stock as Shares Fell 45% From Their Record High. Wall Street's Median Price Target Is $243.81, 111.5% Above the Current Close.
27-07-2026
fool.com
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
27-07-2026
yahoo.com
Scribe’s Genetic Editing Aims to Prevent Heart Attacks
27-07-2026
yahoo.com
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
28-07-2026
yahoo.com
Earnings Preview: Ultragenyx (RARE) Q2 Earnings Expected to Decline
28-07-2026
yahoo.com
3 Mid-Cap Growth Stocks With Monstrous Long-Term Upside
28-07-2026
fool.com
What is the current price of CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The current price of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is $47.55.
CRISPR THERAPEUTICS AG (CRSP:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) since the previous trading day is $0.82.
CRISPR THERAPEUTICS AG (CRSP:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRISPR THERAPEUTICS AG (CRSP:NASDAQ) since the previous trading day is 1.7548%.
What is the most recent average sentiment score for CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The most recent average sentiment score for CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for CRISPR THERAPEUTICS AG (CRSP:NASDAQ)?
The most recent sentiment for CRISPR THERAPEUTICS AG (CRSP:NASDAQ) is .
SEC-8K** Filing Available For CRISPR THERAPEUTICS AG (CRSP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.